Your session is about to expire
← Back to Search
N/A
Computerized Cognitive Tests for Neurological Disease
N/A
Recruiting
Led By Alexander Chervinsky, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants will be male or female and between the ages of 21 and 65 years old.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial is testing three new computerized tests that will measure brain/cognitive functioning. The tests will be given to both healthy controls and neurologically impaired patients to see how well they work.
Who is the study for?
This trial is for men and women aged 21-65, both healthy individuals and those with significant brain findings on neuroimaging. Participants must have good perception and motor skills to do the tests but can't join if they have severe dementia or lack the necessary perceptual/motor abilities.Check my eligibility
What is being tested?
The study is testing three new computer-based cognitive function tests against traditional paper-and-pencil methods. It aims to see if these digital tasks are more effective by comparing results from healthy controls and patients with neurological impairments.See study design
What are the potential side effects?
Since this trial involves non-invasive neuropsychological testing, there are no direct physical side effects expected from participating in this study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 21 and 65 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Score on President Recognition Test
Score on Railroad Test
Score on Swamp Test
Trial Design
2Treatment groups
Active Control
Group I: Non-CNI participantsActive Control10 Interventions
Identified from the department of Rehabilitation, Psychiatry, and Medicine and referred to the research staff via in-person communication, email or staff message
Group II: Cerebral neurological illness (CNI) participantsActive Control10 Interventions
Identified from the department of Rehabilitation, Psychiatry, and Medicine and referred to the research staff via in-person communication, email or staff message
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,372 Previous Clinical Trials
840,910 Total Patients Enrolled
Alexander Chervinsky, PhDPrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am physically and mentally able to participate in tests.I am between 21 and 65 years old.I do not have severe dementia that affects my understanding.I am between 21 and 65 years old.I can see, hear, and move well enough to take part in tests.
Research Study Groups:
This trial has the following groups:- Group 1: Non-CNI participants
- Group 2: Cerebral neurological illness (CNI) participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger